Technical Analysis for MEIP - MEI Pharma, Inc.

Grade Last Price % Change Price Change
grade C 2.0 0.50% 0.01
MEIP closed up 0.5 percent on Wednesday, September 18, 2019, on 86 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical MEIP trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Walk Strength 0.50%
Wide Bands Range Expansion 0.50%
Overbought Stochastic Strength 0.50%
Upper Bollinger Band Touch Strength 0.50%
Shooting Star Candlestick Bearish 0.25%
New Uptrend Bullish 0.25%

Older signals for MEIP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
MEIP Chart by TradingView
Basic chart:
Profile
MEI Pharma, Inc., a development stage oncology company, focuses on the clinical development of therapeutics for the treatment of cancer. It develops various lead drug candidates, including ME-143 that has completed Phase I clinical trials in patients with refractory solid tumors; ME-344, an active metabolite of NV-128, which is in Phase I clinical trials in patients with solid refractory tumors; and Pracinostat, an orally histone deacetylase inhibitor that has completed various Phase I clinical trials in patients with hematologic disorders. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was founded in 2000 and is based in San Diego, California. MEI Pharma, Inc. is a subsidiary of Novogen Limited. MEI Pharma, Inc. (NasdaqCM:MEIP) operates independently of Novogen Limited as of December 03, 2012.
Medicine Cancer Clinical Medicine Treatment Of Cancer Virotherapy Seattle Genetics Kite Pharma Hematologic Disorders Refractory Solid Tumors
Is MEIP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Sep 18 A Holistic Look At MEI Pharma, Inc. (NASDAQ:MEIP)
Aug 29 MEI Pharma to Present at the 2019 Wells Fargo Healthcare Conference
Aug 29 Edited Transcript of MEIP earnings conference call or presentation 28-Aug-19 9:00pm GMT
Aug 29 MEI Pharma, Inc. (MEIP) CEO Daniel Gold on Q4 2019 Results - Earnings Call Transcript
Aug 28 MEI Pharma EPS misses by $0.14, beats on revenue
Aug 28 MEI Pharma Reports Fiscal Year 2019 Results and Operational Highlights
Aug 28 The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved
Aug 28 Earnings Scheduled For August 28, 2019
Aug 25 The Week Ahead In Biotech: A Quiet One Ahead Of Labor Day Weekend
Aug 21 MEI Pharma to Release 2019 Fiscal Year End Financial Results and Provide Corporate Update on August 28, 2019
See more MEIP news...
Indicators
Indicator Value
52 Week High 4.61
52 Week Low 1.44
Average Volume 306,619
200-Day Moving Average 2.5477
50-Day Moving Average 1.7631
20-Day Moving Average 1.7793
10-Day Moving Average 1.8905
Average True Range 0.118
ADX 25.95
+DI 23.0061
-DI 13.1939
Chandelier Exit (Long, 3 ATRs ) 1.716
Chandelier Exit (Short, 3 ATRs ) 1.854
Upper Bollinger Band 2.0699
Lower Bollinger Band 1.4887
Percent B (%b) 0.88
BandWidth 32.664531
MACD Line 0.0672
MACD Signal Line 0.0272
MACD Histogram 0.04
Fundamentals Value
Market Cap 73.88 Million
Num Shares 36.9 Million
EPS 0.07
Price-to-Earnings (P/E) Ratio 28.57
Price-to-Sales 4.35
Price-to-Book 1.98
PEG Ratio 23.80
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.18
Resistance 3 (R3) 2.17 2.09 2.15
Resistance 2 (R2) 2.09 2.05 2.10 2.14
Resistance 1 (R1) 2.05 2.02 2.06 2.06 2.13
Pivot Point 1.97 1.97 1.98 1.98 1.97
Support 1 (S1) 1.93 1.93 1.94 1.94 1.87
Support 2 (S2) 1.85 1.90 1.86 1.86
Support 3 (S3) 1.81 1.85 1.85
Support 4 (S4) 1.82